Regulatory reforms will boost African vaccine production and access
Nat Med
.
2024 Dec;30(12):3409-3412.
doi: 10.1038/s41591-024-03314-x.
Authors
Niteen Wairagkar
1
,
Alex Juma Ismail
2
,
Dalia M N Abouhussein
3
,
Moji Christianah Adeyeye
4
,
Delese Mimi Darko
5
,
Adam Mitangu Fimbo
6
,
Richard T Rukwata
7
,
Boitumelo Tumi Semete-Makokotlela
8
,
Michele Sidibe
9
,
Nicaise Ndembi
10
Affiliations
1
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
2
African Medicines Harmonization Initiative, AUDA NEPAD, Johannesburg, South Africa.
3
Egyptian Drug Authority, Cairo, Egypt.
4
The National Agency for Food and Drug Administration and Control, Abuja, Nigeria.
5
Ghana Food and Drugs Authority, Accra, Ghana.
6
Food and Drugs Authority Tanzania, Dodoma, United Republic of Tanzania.
7
Medicines Control Authority of Zimbabwe, Harare, Zimbabwe.
8
South African Health Products Regulatory Authority, Pretoria, South Africa.
9
African Medicines Agency, Addis Ababa, Ethiopia.
10
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. nicaise.ndembi@ihv.umaryland.edu.
PMID:
39472758
DOI:
10.1038/s41591-024-03314-x
No abstract available